Zobrazeno 1 - 10
of 618
pro vyhledávání: '"Esser-Nobis K"'
Autor:
Colasanti O; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Burm R; Laboratory of Liver Infectious Diseases, Ghent University, Ghent, Belgium., Huang HE; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Riedl T; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Traut J; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Gillich N; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany., Li TF; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Corneillie L; Laboratory of Liver Infectious Diseases, Ghent University, Ghent, Belgium., Faure-Dupuy S; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Grünvogel O; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Heide D; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lee JY; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Tran CS; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Merle U; Internal Medicine IV, Department of Gastroenterology, Heidelberg University Hospital, Heidelberg, Germany., Chironna M; Interdisciplinary Department of Medicine, University of Bari, Bari, Italy., Vondran FFW; Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany; German Centre for Infection Research (DZIF), Partner Site Hannover, Hannover, Germany., Esser-Nobis K; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Binder M; Research Group 'Dynamics of Early Viral Infection and the Innate Antiviral Response', Division 'Virus-Associated Carcinogenesis', German Cancer Research Centre (DKFZ), Heidelberg, Germany., Bartenschlager R; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; The M3 Research Institute, Medical Faculty Tuebingen (MTF), Tuebingen, Germany., Meuleman P; Laboratory of Liver Infectious Diseases, Ghent University, Ghent, Belgium., Lohmann V; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany. Electronic address: Volker.Lohmann@med.uni-heidelberg.de.
Publikováno v:
Journal of hepatology [J Hepatol] 2024 Jan; Vol. 80 (1), pp. 171-172. Date of Electronic Publication: 2023 Nov 30.
Autor:
Colasanti O; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Burm R; Laboratory of Liver Infectious Diseases, Ghent University, Ghent, Belgium., Huang HE; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Riedl T; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Traut J; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Gillich N; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany., Li TF; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Corneillie L; Laboratory of Liver Infectious Diseases, Ghent University, Ghent, Belgium., Faure-Dupuy S; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Grünvogel O; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Heide D; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lee JY; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Tran CS; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Merle U; Internal Medicine IV, Department of Gastroenterology, Heidelberg University Hospital, Heidelberg, Germany., Chironna M; Interdisciplinary Department of Medicine, University of Bari, Bari, Italy., Vondran FFW; Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany; German Centre for Infection Research (DZIF), Partner Site Hannover, Hannover, Germany., Esser-Nobis K; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany., Binder M; Research Group 'Dynamics of Early Viral Infection and the Innate Antiviral Response', Division 'Virus-Associated Carcinogenesis', German Cancer Research Centre (DKFZ), Heidelberg, Germany., Bartenschlager R; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany., Heikenwälder M; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; The M3 Research Institute, Medical Faculty Tuebingen (MTF), Tuebingen, Germany., Meuleman P; Laboratory of Liver Infectious Diseases, Ghent University, Ghent, Belgium., Lohmann V; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, University of Heidelberg, Heidelberg, Germany; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany. Electronic address: Volker.Lohmann@med.uni-heidelberg.de.
Publikováno v:
Journal of hepatology [J Hepatol] 2023 Sep; Vol. 79 (3), pp. 645-656. Date of Electronic Publication: 2023 Apr 29.
Autor:
Puyskens A; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Bayram F; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Sesver A; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Michel J; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Krause E; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Bourquain D; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Filomena A; Paul-Ehrlich-Institute, Testing Laboratory for In-vitro Diagnostic Medical Devices, Langen, Germany., Esser-Nobis K; Paul-Ehrlich-Institute, Testing Laboratory for In-vitro Diagnostic Medical Devices, Langen, Germany., Steffanowski C; Paul-Ehrlich-Institute, Testing Laboratory for In-vitro Diagnostic Medical Devices, Langen, Germany., Nübling CM; Paul-Ehrlich-Institute, Division Major Policy Issues, Coordination, Langen, Germany., Scheiblauer H; Paul-Ehrlich-Institute, Testing Laboratory for In-vitro Diagnostic Medical Devices, Langen, Germany., Schaade L; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany., Nitsche A; Robert Koch Institute, Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2023 Apr; Vol. 28 (16).
Autor:
Scheiblauer H; Paul-Ehrlich-Institute, IVD Testing Laboratory, Langen, Germany. Electronic address: schhe@pei.de., Nübling CM; Paul-Ehrlich-Institute, Division Major Policy Issues, Coordination, Langen, Germany., Wolf T; University Hospital Frankfurt - Department of Infectious Diseases and HIV, Goethe University Frankfurt, Frankfurt am Main, Germany., Khodamoradi Y; University Hospital Frankfurt - Department of Infectious Diseases and HIV, Goethe University Frankfurt, Frankfurt am Main, Germany., Bellinghausen C; University Hospital Frankfurt - Department of Respiratory Medicine and Allergology, Goethe University Frankfurt, Frankfurt am Main, Germany., Sonntagbauer M; University Hospital Frankfurt - Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Goethe University Frankfurt, Frankfurt am Main, Germany., Esser-Nobis K; Paul-Ehrlich-Institute, IVD Testing Laboratory, Langen, Germany., Filomena A; Paul-Ehrlich-Institute, IVD Testing Laboratory, Langen, Germany., Mahler V; Paul-Ehrlich-Institute, Division Allergology, Langen, Germany., Maier TJ; Paul-Ehrlich-Institute, Division Safety of Medicinal Products and Medical Devices, Langen, Germany., Stephan C; University Hospital Frankfurt - Department of Infectious Diseases and HIV, Goethe University Frankfurt, Frankfurt am Main, Germany.
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2022 Jan; Vol. 146, pp. 105052. Date of Electronic Publication: 2021 Dec 04.
Autor:
Soveg FW; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Schwerk J; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Gokhale NS; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Cerosaletti K; Benaroya Research Institute at Virginia Mason, Seattle, United States., Smith JR; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Pairo-Castineira E; Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom., Kell AM; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.; Department of Molecular Genetics and Microbiology, School of Medicine, University of New Mexico, Albuquerque, United States., Forero A; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, United States., Zaver SA; Department of Microbiology, School of Medicine, University of Washington, Seattle, United States., Esser-Nobis K; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Roby JA; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Hsiang TY; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Ozarkar S; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Clingan JM; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., McAnarney ET; Department of Microbiology and Immunology, University of Texas Medical Center, Galveston, United States., Stone AE; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.; Department of Basic Sciences, College of Osteopathic Medicine, Touro University Nevada, Henderson, United States., Malhotra U; Department of Infectious Disease, Virginia Mason Medical Center, Seattle, United States.; Department of Medicine, Section of Infectious Diseases, University of Washington, Seattle, United States., Speake C; Benaroya Research Institute at Virginia Mason, Seattle, United States., Perez J; Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, United States., Balu C; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Allenspach EJ; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, United States., Hyde JL; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, United States., Menachery VD; Department of Microbiology and Immunology, University of Texas Medical Center, Galveston, United States., Sarkar SN; Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, United States., Woodward JJ; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.; Department of Microbiology, School of Medicine, University of Washington, Seattle, United States., Stetson DB; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Baillie JK; Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom.; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom., Buckner JH; Benaroya Research Institute at Virginia Mason, Seattle, United States., Gale M Jr; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States., Savan R; Department of Immunology, School of Medicine, University of Washington, Seattle, United States.; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, United States.
Publikováno v:
ELife [Elife] 2021 Aug 03; Vol. 10. Date of Electronic Publication: 2021 Aug 03.
Autor:
Xu, Wenqi1,2 (AUTHOR) sigrid.langhans@nemours.org, Langhans, Sigrid A.2,3 (AUTHOR), Johnson, David K.4 (AUTHOR) dkjohnson@ku.edu, Stauff, Erik1,2 (AUTHOR) erik.stauff@nemours.org, Kandula, Vinay V. R.1 (AUTHOR) vinay.kandula@nemours.org, Kecskemethy, Heidi H.1,2 (AUTHOR) heidi.kecskemethy@nemours.org, Averill, Lauren W.1,2 (AUTHOR) lauren.averill@nemours.org, Yue, Xuyi1,2 (AUTHOR) xuyi.yue@nemours.org
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9419. 22p.
Autor:
Sun, Zitao1,2 (AUTHOR) jinxin@ybu.edu.cn, Wang, Yanjin1 (AUTHOR) wangyanjin1996@126.com, Jin, Xin2 (AUTHOR), Li, Su1 (AUTHOR) lisu@caas.cn, Qiu, Hua-Ji1 (AUTHOR) lisu@caas.cn
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9206. 16p.
Autor:
Huang, Zhengrui1 (AUTHOR), Sun, Lu1 (AUTHOR), Gao, Yudie1 (AUTHOR), Shi, Meiting1 (AUTHOR), Zhang, Ping1 (AUTHOR), Ding, Yuzhen2 (AUTHOR), Wang, Jian1 (AUTHOR), Wei, Jiachun1 (AUTHOR), Yang, Xiuli3 (AUTHOR) yangxiuli@163.com, Li, Ruiman1 (AUTHOR) hqyylrm@126.com
Publikováno v:
BMC Pregnancy & Childbirth. 8/15/2024, Vol. 24 Issue 1, p1-17. 17p.
Autor:
Linsky TW; Neoleukin Therapeutics Inc., Seattle, WA, USA., Vergara R; Neoleukin Therapeutics Inc., Seattle, WA, USA., Codina N; Neoleukin Therapeutics Inc., Seattle, WA, USA., Nelson JW; Neoleukin Therapeutics Inc., Seattle, WA, USA., Walker MJ; Neoleukin Therapeutics Inc., Seattle, WA, USA., Su W; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China., Barnes CO; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA., Hsiang TY; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Esser-Nobis K; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Yu K; Neoleukin Therapeutics Inc., Seattle, WA, USA., Reneer ZB; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA., Hou YJ; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Priya T; Neoleukin Therapeutics Inc., Seattle, WA, USA., Mitsumoto M; Neoleukin Therapeutics Inc., Seattle, WA, USA., Pong A; Neoleukin Therapeutics Inc., Seattle, WA, USA., Lau UY; Neoleukin Therapeutics Inc., Seattle, WA, USA., Mason ML; Neoleukin Therapeutics Inc., Seattle, WA, USA., Chen J; Neoleukin Therapeutics Inc., Seattle, WA, USA., Chen A; Neoleukin Therapeutics Inc., Seattle, WA, USA., Berrocal T; Neoleukin Therapeutics Inc., Seattle, WA, USA., Peng H; Neoleukin Therapeutics Inc., Seattle, WA, USA., Clairmont NS; Neoleukin Therapeutics Inc., Seattle, WA, USA., Castellanos J; Neoleukin Therapeutics Inc., Seattle, WA, USA., Lin YR; Neoleukin Therapeutics Inc., Seattle, WA, USA., Josephson-Day A; Neoleukin Therapeutics Inc., Seattle, WA, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Fuller DH; Department of Microbiology, University of Washington, Seattle, WA, USA., Walkey CD; Neoleukin Therapeutics Inc., Seattle, WA, USA., Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.; Department of Infectious Diseases, University of Georgia, Athens, GA, USA., Swanson R; Neoleukin Therapeutics Inc., Seattle, WA, USA., Bjorkman PJ; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, USA., Blancas-Mejia LM; Neoleukin Therapeutics Inc., Seattle, WA, USA., Yen HL; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China., Silva DA; Neoleukin Therapeutics Inc., Seattle, WA, USA. dadriano@neoleukin.com.
Publikováno v:
Science (New York, N.Y.) [Science] 2020 Dec 04; Vol. 370 (6521), pp. 1208-1214. Date of Electronic Publication: 2020 Nov 05.
Autor:
Fay EJ; Biochemistry, Molecular Biology and Biophysics Graduate Program, University of Minnesota, Minneapolis MN, United States of America.; Center for Immunology, University of Minnesota, Minneapolis MN, United States of America., Aron SL; Department of Microbiology and Immunology, University of Minnesota, Minneapolis MN, United States of America., Macchietto MG; Institute for Health Informatics, University of Minnesota, Minneapolis MN, United States of America., Markman MW; Department of Microbiology and Immunology, University of Minnesota, Minneapolis MN, United States of America., Esser-Nobis K; Department of Immunology and Center for Innate Immunity and Immune Disease, University of Washington, Seattle WA, United States of America., Gale M Jr; Department of Immunology and Center for Innate Immunity and Immune Disease, University of Washington, Seattle WA, United States of America., Shen S; Institute for Health Informatics, University of Minnesota, Minneapolis MN, United States of America., Langlois RA; Biochemistry, Molecular Biology and Biophysics Graduate Program, University of Minnesota, Minneapolis MN, United States of America.; Center for Immunology, University of Minnesota, Minneapolis MN, United States of America.; Department of Microbiology and Immunology, University of Minnesota, Minneapolis MN, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2020 Aug 13; Vol. 16 (8), pp. e1008760. Date of Electronic Publication: 2020 Aug 13 (Print Publication: 2020).